In 2024/25, health accounted for £242 billion of government expenditure, representing 19 per cent of total public spending ...
A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results Waltham, MASS., (April 16, 2026) – ...
Nearly one in three adults in England are already living with obesity,[i] and by 2040 more people will be affected by obesity than be a healthy weight.[ii]Just 3% of adults living with obesity or who ...
A study issued by M42 in partnership with the Department of Health – Abu Dhabi demonstrates how genomics enables prevention ...
The custom antibody market is projected to grow at a CAGR of approximately 10% throughout the forecast period. This expansion is driven by increasing R&D activity, rising demand for highly specific ...
Ondine Biomedical Inc. (LON: OBI), a leader in photodisinfection-based therapies, is pleased to announce that two of its abstracts have been accepted for poster presentation at the upcoming World ...
FDA Fast Track Designation granted to 4P004 for the treatment of knee osteoarthritis, recognizing the disease as a serious ...
UPPSALA, SE / ACCESS Newswire / April 22, 2026 / Senzime (STO:SEZI) (OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - March 2026 is now available on the company's website information ...
X AB (“2cureX” or the “Company”) today announces that it has successfully completed an oversubscribed directed share issue of 6,800,000 shares to a select group of international investors (the ...
Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006  in Hepatic EncephalopathyStrong global consensus on ...
The randomized Phase 2b ASPIRE trial successfully completed planned enrollment of over 360 patients, reflecting strong execution and robust site engagementASPIRE is designed to assess the effect of ...
University of Kent researchers reveal that a Centella asiatica compound could combat antibiotic resistant bacteria, offering ...